B0753
2,3-Butanedione monoxime
≥98% (GC), powder, ATP-sensitive K⁺ and Ca²⁺ channel inhibitor
Sinónimos:
BDM
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Fórmula lineal:
CH3C(=NOH)COCH3
Número de CAS:
Peso molecular:
101.10
Beilstein:
605582
Número CE:
Número MDL:
Código UNSPSC:
12352200
ID de la sustancia en PubChem:
NACRES:
NA.77
Productos recomendados
product name
2,3-Butanedione monoxime, ≥98%
Análisis
≥98%
formulario
powder
bp
185-186 °C (lit.)
mp
75-78 °C (lit.)
cadena SMILES
CC(=O)\C(C)=N\O
InChI
1S/C4H7NO2/c1-3(5-7)4(2)6/h7H,1-2H3/b5-3+
Clave InChI
FSEUPUDHEBLWJY-HWKANZROSA-N
Información sobre el gen
human ... KCNB1(3745)
¿Está buscando productos similares? Visita Guía de comparación de productos
Aplicación
2,3-Butanedione monoxime has been used:
- in single-molecule myosin V motility assays
- as an anesthetic in the approach of imaging transgenic animals
- to reduce rigor tension in muscle fibres
- as a media component for mice cardiomyocytes culture
Acciones bioquímicas o fisiológicas
2,3-Butanedione monoxime is inhibitor of ATP-sensitive K+ and Ca2+ channels.
DRK1 is a delayed rectifier (Kv2.1) cloned K+ channel from rat brain with consensus sites for protein kinase-dependent phosphorylation that might be expected to be functionally regulated by phosphorylation. 2,3-Butanedione monoxime (BDM) chemically removes phosphate groups from many proteins, and its action on DRK1 channels was examined after expression of DRK1 cRNA in Xenopus oocytes. In two-microelectrode voltage-clamp experiments, the application of 2,3-Butanedione monoxime to the bath inhibited DRK1 current (ki = 16.6 mM, H = 0.96) rapidly and reversibly, with a time course similar to the time course of solution change within the bath. DRK1 current was inhibited at all potentials; the time course of current activation, deactivation and inactivation were unaffected by 2,3-Butanedione monoxime. In inside-out patch-clamp experiments, the application of 2,3-Butanedione monoxime to the cytoplasmic surface similarly inhibited channel activity rapidly and reversibly (ki = 10.7 mM, H = 1.01) in the absence of rephosphorylating substrates. These results are inconsistent with a phosphatase effect, because such an effect should be irreversible in cell-free, ATP-free patches. Instead, the results suggest that 2,3-Butanedione monoxime can inhibit DRK1 channels directly from inside or outside of the membrane.
Código de clase de almacenamiento
11 - Combustible Solids
Clase de riesgo para el agua (WGK)
WGK 3
Punto de inflamabilidad (°F)
Not applicable
Punto de inflamabilidad (°C)
Not applicable
Equipo de protección personal
Eyeshields, Gloves, type N95 (US)
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Los clientes también vieron
Deficiency of mouse mast cell protease 4 mitigates cardiac dysfunctions in mice after myocardium infarction
Wang Yunzhe, et al.
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease (2019)
A transgenic approach to live imaging of heparan sulfate modification patterns
Glycosaminoglycans, 253-268 (2015)
M L Riccio et al.
Circulation research, 84(8), 955-963 (1999-05-01)
Despite recent advances in our understanding of the mechanism for ventricular fibrillation (VF), important electrophysiological aspects of the development of VF still are poorly defined. It has been suggested that the onset of VF involves the disintegration of a single
Masahito Miura et al.
Circulation, 121(25), 2711-2717 (2010-06-16)
Arrhythmias are benign or lethal, depending on their sustainability and frequency. To determine why lethal arrhythmias are prone to occur in diseased hearts, usually characterized by nonuniform muscle contraction, we investigated the effect of nonuniformity on sustainability and frequency of
Qing Lou et al.
American journal of physiology. Heart and circulatory physiology, 302(1), H262-H269 (2011-11-01)
Unlike other excitation-contraction uncouplers, blebbistatin has few electrophysiological side effects and has gained increasing acceptance as an excitation-contraction uncoupler in optical mapping experiments. However, the possible role of blebbistatin in ventricular arrhythmia has hitherto been unknown. Furthermore, experiments with blebbistatin
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico